Alerts will be sent to your verified email
Verify Email
GENNEX
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Gennex Laboratories Ltd specializes in the production and export of bulk drugs and intermediates such as Guaiphenesin, Methocarbamol, Fluconazole, and Phenazopyridine.
Gennex Lab major competitors are Vaidya Sane Ayur Lab, Lyka Labs, Ambalal Sarabhai Ent, Coral Laboratories, Achyut Healthcare, Panchsheel Organics, Kimia Biosciences.
Market Cap of Gennex Lab is ₹208 Crs.
While the median market cap of its peers are ₹137 Crs.
Gennex Lab seems to be less financially stable compared to its competitors.
Altman Z score of Gennex Lab is 3.9 and is ranked 5 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Jun | ||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
